DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n8vjzj/glaucoma) has announced the addition of the "Glaucoma Partnering 2009-2014" report to their offering.
Glaucoma Partnering 2009-2014 report provides understanding and access to the glaucoma partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in glaucoma partnering deals
- Top glaucoma deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type
Glaucoma Partnering 2009-2014 provides understanding and access to the glaucoma partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides an analysis of glaucoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors glaucoma technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of glaucoma technologies and products.
Glaucoma Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to glaucoma trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
- Trends in glaucoma dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- The leading glaucoma deals by value since 2009
In Glaucoma Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in glaucoma partnering
Chapter 3 - Leading glaucoma deals
Chapter 4 - Dealmaking directory
Chapter 5 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/n8vjzj/glaucoma